30Dec 2019

RISK FACTORS FOR BREAST CANCER RECURRENCE : ABOUT 310 CASES

  • Department of Radiotherapy, Mohammed V Military Teaching Hospital, Mohammed V University in Rabat - Morocco
  • Department of Gynecology, Mohammed V Military Teaching Hospital, Mohammed V University in Rabat - Morocco
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Purpose: To retrospectively study our risk factors for breast cancer recurrence and compare them with data from the literature. Materials and Methods: Through the analysis of 310 patients admitted to the radiotherapy department of the Mohammed V Military Teaching Hospital in Rabat between January 2009 and December 2015, we identified local, locoregional and / or systemic recurrence factors. Results: The mean age was 49.15 ? 10.37 years, the mean parity was 3.3 ? 2, 43.5% were postmenopausal, 18.3% had a family history of breast cancer, and 41.3% used oral contraception. According to the TNM classification, 49.8% were classified as stage IIA. Invasive ductal carcinoma was predominant (82.6%). For the histo-prognosis grade of Scarf-Bloom and Richardson (SBR), 91% of patients were classified as SBR II and III. Lymphovascular invasion (LVI) were positive in 44.2%, and hormone receptors (HR) were positive in 75.8%. Lymph node involvement ≥4 nodes was noted in 28.5% of patients. In univariate analysis, the presence of LVI (p <0.001), N≥4 (p <0.025) and RH negative (p <0.021) were statistically significant risk factors for recurrence. While in multivariate analysis, only EV (p <0.035) and HR negativity (p <0.012) were statistically significant. Conclusion: Our study highlights known risk factors namely massive ganglionic invasion, lymphovascular invasion and hormone receptors. Other factors must be studied to improve the future management of our patients.

  1. Bray F,?Ferlay J,?Soerjomataram I,?Siegel RL,?Torre LA,?Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.2018 Nov68(6):394-424.
  2. Tazi MA, Er-Raki A, Benjaafar N. Cancer incidence in Rabat, Morocco: 2006?2008. E cancer medical science 20137:338?50.
  3. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM et al. Prognosticfactors in breast cancer. College of American Pathologists Consensus Statement 1999.Arch Pathol Lab Med 2000 124 : 966-978
  4. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al., Early Breast Cancer Trialists? Collaborative Group(EBCTCG). Effects of radiotherapy and of differences in theextent of surgery for early breast cancer on local recurrenceand 15-year survival: an overview of the randomisedtrials.Lancet 2005366:2087?106.
  5. Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate ofaxillary failure in patients with four or more positive lymphnodes. Int J RadiatOncolBiolPhys 200356:658?70.
  6. Truong PT, Olivotto IA, Kader HA, Panades M, SpeersCH,Berthelet E. Selecting breast cancer patients with T1-T2tumors and one to three positive axillary nodes at highpostmastectomylocoregional recurrence risk for adjuvantradiotherapy. Int J RadiatOncolBiolPhys 200561:1337?47.
  7. Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, et al.Treatment results and prognostic factors of early breast cancertreated with a breast conserving operation and radiotherapy.Jpn J ClinOncol 200535:126?33.
  8. Komoike Y, Akiyama F, Iino Y, Ikeda T, Tanaka-Akashi S,Ohsumi S, et al. Analysis of ipsilateral breast tumor recurrencesafter breast-conserving treatment based on the classificationof true recurrences and new primary tumors. Breast Cancer200512:104?11.
  9. Dunst J, Steil B, Furch S, Fach A, LautenschlagerC,Diestelhorst A, et al. Prognostic significance of local recurrencein breast cancer after postmastectomy radiotherapy. StrahlentherOnkol 2001177:504?10.
  10. Van Der Wal BC, Butzelaar RM, Van Der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removedlymph nodes: predictors of survival in stage I and II breast cancer.Eur J SurgOncol. 200228:481?9.
  11. Kim J, Kim JH, Kim OB, Oh YK, Park SG. Clinical significance of the lymph node ratio in N1 breast cancer.RadiatOncol J. 201735(3):227?232.
  12. Cheng JC, Chen CM, Liu MC, Tsou MH, Yang PS, Jian JJ, et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. IntJRadiatOncolBiolPhys 200252:980?8.
  13. Truong PT, Olivotto IA, Speers CH, Wai ES, BertheletE,Kader HA. A positive margin is not always an indication forradiotherapy after mastectomy in early breast cancer. IntJRadiatOncolBiolPhys 200458:797?804.
  14. Truong PT, Lesperance M, Culhaci A, Kader HA, SpeersCH,Olivotto IA. Patient subsets with T1-T2, node-negative breastcancer at high locoregional recurrence risk after mastectomy.Int J RadiatOncolBiolPhys 200562:175?82.
  15. Truong PT, Yong CM, Abnousi F, Lee J, Kader HA, Hayashi A,et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negativebreast cancer treated with mastectomy and systemic therapy.J Am CollSurg 2005200:912?21.
  16. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized studycomparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002347:1227?32.
  17. Song YJ, Shin SH, Cho JS, Park MH, Yoon JH, Jegal YJ. The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer.J Breast Cancer. 201114(3):198?203.
  18. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clinical cancer research : an official journal of the American Association for Cancer Research. 200713(15 Pt 1):4429-34.
  19. Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004100:1823?32
  20. Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, et al. Patients with early stage invasive cancer withclose or positive margins treated with conservative surgery andradiation have an increased risk of breast recurrence that isdelayed by adjuvant systemic therapy. Int J RadiatOncolBiolPhys 199944:1005?15.
  21. Freedman GM, Fowble BL, Hanlon AL, Myint MA, Hoffman JP,Sigurdson ER, et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation exceptin women aged fifty or younger. Int J RadiatOncolBiolPhys19984:599?605.
  22. Meric F, Mirza NQ, Vlastos G, Buchholz TA, KuererHM,Babiera GV, et al. Positive surgical margins and ipsilateralbreast tumor recurrence predict disease-specific survival afterbreast-conserving therapy. Cancer 200397:926-33.

[Abdelhak Maghous, Mohamed Elmarjany, El - Amin Marnouch, Maroa Belemlih, Mohcine Hommadi, Noha Zaghba, Khalid Andaloussi Saghir, Baba Habib, Jaouad Kouach, Hassan Sifat, Hamid Mansouri and Khalid Hadadi (2019); RISK FACTORS FOR BREAST CANCER RECURRENCE : ABOUT 310 CASES Int. J. of Adv. Res. 7 (Dec). 724-730] (ISSN 2320-5407). www.journalijar.com

abdelhak maghous
radiation oncologist

DOI:

Article DOI: 10.21474/IJAR01/10201      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10201

Download Full Paper

Download PDF No. of Downloads: 17 | No. of Views: 57